All Updates

The following was originally published in the Albany Times Union on March 21, 2024. Over the past 30 years, the risk of dying from cancer has steadily declined. This trend can partially be explained by declines in smoking rates, progress in early cancer detection and advances in

Nation’s Leading Cancer Advocacy Organization Urges Support of LD2028 Minority Report to Protect Public Health

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion.

ATLANTA, Georgia – March 21, 2024 – The Georgia Senate’s regulated industries committee failed to pass HB 1077 today in a tied vote. The bill would have cleared the way for a customized solution to closing the coverage gap in Georgia. PeachCare Plus would help nearly 450,000 Georgians access

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion.

Today, the American Cancer Society Cancer Action Network submitted a statement for the record to the House Energy & Commerce Committee Health Subcommittee in regards to their hearing on Evaluating Approaches to Diagnostic Test Regulation and the impact of the FDA’s proposed rule.

As one of the leading patient advocacy groups that advocated for the passage of the Affordable Care Act (ACA), the American Cancer Society Cancer Action Network (ACS CAN) is celebrating the impact of the historic law ahead of its 14th anniversary on Saturday. ACS CAN is marking the milestone by urging Congress, state lawmakers and the U.S. Court of Appeals for the Fifth Circuit to protect and strengthen the critical patient protections of the ACA.

Rhode Island lawmakers have taken the first step towards improving prescription drug affordability for cancer patients and others with chronic diseases.